Incorporating quality of evidence into decision analytic modeling (Q36285963)

13 August 2017

Incorporating quality of evidence into decision analytic modeling (English)

1 reference

13 August 2017

3

Amy C Justice

1 reference

13 August 2017

R Scott Braithwaite

1

1 reference

13 August 2017

Mark S Roberts

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Annals of Internal Medicine

13 August 2017

1 reference

13 August 2017

146

1 reference

13 August 2017

2

1 reference

13 August 2017

133-141

1 reference

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Estimating the proportion of patients infected with HIV who will die of comorbid diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Rating the strength of scientific evidence: relevance for quality improvement programs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Current methods of the US Preventive Services Task Force: a review of the process

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

The hazards of scoring the quality of clinical trials for meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Survival from early, intermediate, and late stages of HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

United States life tables, 2002.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

The cost-effectiveness of preventing AIDS-related opportunistic infections

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Why don't Americans use cost-effectiveness analysis?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

The risk and burden of vertebral fractures in Sweden

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Swedish population health-related quality of life results using the EQ-5D.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Representing uncertainty: the role of cost-effectiveness acceptability curves

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

An introduction to a Bayesian method for meta-analysis: The confidence profile method

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460380

Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group

22 September 2018

1 reference

12 December 2020

Estimating the rate of accumulating drug resistance mutations in the HIV genome

1 reference

12 December 2020

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

12 December 2020

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis

1 reference

12 December 2020

A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

1 reference

12 December 2020

10.7326/0003-4819-146-2-200701160-00008

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

17227937

1 reference